The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Dupilumab is prescribed for treating moderate ... by GlobalData have expressed enthusiasm about the progress of this mechanism of action. Positive outcomes from clinical trials for both SAR444656 ...

Fewer than 10% of children or adolescents with peanut allergy passed a desnsitiaztion food challenge after receiving dupilumab for 24 weeks. Image: Adobe Stock “The impact of the findings for ...

Sanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal ... The data showed strong evidence of mechanism and antitumor activity in multiple tumor types shown to be ...